In this episode of “Intention to Treat,” a study participant and a long-time investigator of hallucinogenic drugs for psychiatric conditions illuminate the effects of psilocybin in patients with depression.
A full transcript of this episode is available at <a href='https://www.nejm.org/doi/full/10.1056/NEJMp2300936'>https://www.nejm.org/doi/full/10.1056/NEJMp2300936</a>.

In this episode of “Intention to Treat,” a study participant and a long-time investigator of hallucinogenic drugs for psychiatric conditions illuminate the effects of psilocybin in patients with depression. A full transcript of this episode is available at https://www.nejm.org/doi/full/10.1056/NEJMp2300936.

In this episode of “Intention to Treat,” a study participant and a long-time investigator of hallucinogenic drugs for psychiatric conditions illuminate the effects of psilocybin in patients with depression.
A full transcript of this episode is available at <a href="https://www.nejm.org/doi/full/10.1056/NEJMp2300936" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMp2300936</a>.

The Promise and Perils of Psychedelics

From the New England Journal of Medicine, welcome to “Intention to Treat,” a podcast exploring the most complicated, perplexing, and fascinating issues facing medicine today. From groundbreaking research, to clinical advances, to personal stories from doctors and their patients, we give you a behind-the-scenes look at discoveries that are changing medical practice and provide you with the knowledge to thrive on the front lines of health care.

Share The Promise and Perils of Psychedelics

Sign up to save your podcasts

The Promise and Perils of Psychedelics

The Promise and Perils of Psychedelics

More shows like Intention to Treat

NEJM This Week

NEJM Interviews

Science Friday

Clinical Conversations

Curbside Consults

Leadership Conversations

NEJM AI Grand Rounds

Not Otherwise Specified